The PANTHER Trial
September 6, 2023 | Marco Valgimigli and C. Michael Gibson discuss the PANTHER trial, which compared P2Y12 inhibitor monotherapy with aspririn monotherapy in patients with coronary artery disease. |
TCTMD Talking Points
2023-09-06T17:30:00Z